Aromatase Inhibitors: Did you decide to go on them or not?
Nanaloves: I’m about to start arimidex and just feel that the contraindications , bone issues etc. are overwhelming. I’m 70 years old, dodged a bullet I feel with zero stage DCIS but the follow up is pretty much no different then if it was more aggressive. I’ve just done 33 treatments of radiation and now they advise arimidex as a preventative. I’m not sure with the beginnings of arthritis and lower back. sensitivity already that I should take it. Anyone not take it and not have a recurrence within the 5 years.
Interested in more discussions like this? Go to the Breast Cancer Support Group.
I would love to see a study/data on results of breast cancer patients who did not choose AI. Thanks
I, too, struggle with similar concerns. My docs at Mayo, told me I didn’t have to have AI or radiation. BUT, they made me feel foolish in not choosing one.
I also have osteopenia and I asked my med-onco about Exemestane (Brand name Aromasin) which is an AI but is also steroidal and protects bones. I’ve been on it for about a month now with no side effects. I guess I could get side effects at any time but for now I’m happy to have none and better bone protection. This is only for post-menopausal women so if you aren’t there yet it’s not for you!
See my comment below. I am also in my 70s and concerned about bone loss as I have osteopenia. There is a steroidal AI that protects against bone loss. It is Exemestane (Brand name is Aromasin). After about a month I have no side effects. Guess I still could but for now I’m happy to have better bone protection.
I feel the same way as you. I have been taking AI for 2 months following a lumpectomy at the end of May. I opted not to have radiation. My oncotype was 5. I have been having some worrisome side effects from the Arimidex: my knees hurt worse than before and my dry eyes are also worse. The hot flashes are also annoying. I am very concerned about the long term effects on bone density, cognition and memory loss. I have been quoted the same percentages of recurrence as you have---6% if I don't take the AI, and 3% if I do. I am seeing my oncologist next month and will probably quit the AI.
@anjalima I finished my full course of an AI 🙂
To others, I did 5 years on letrozole and already had severe osteoporosis. My doc did not want me on Reclast or Prolia (long story) so I was unmedicated. I had a dip in bone density when first on letrozole (similar to the drop at menopause) and then the loss was much much gentler. I am now on Tymlos.
I was more afraid of cancer than any side effects, or bone loss. I felt safe on letrozole. I miss it!
My concern is how the AI will effect my heart. Letrozole is the prescribed drug but I am waiting to take it until I have a CAC scan next week. Am I the only one worried about cardiac calcification and a potential heart attack? Maybe this is not as great a risk as I have cooked up in my mind? (It would be nice to be wrong about this.) I feel like I have to choose between a BC reoccurrence and a heart attack.
My oncologist quotes very different percentages. In late May, I had an invasive DCIS lumpectomy with a lymph node removal that was negative. Surgeon says they got it all. My oncologist says if I don't take AI [anastrozole] I have a 7% chance of a recurrence. If I do take it for 5 years, I have a 3% [absolute] chance of a recurrence. This is making me re-think whether I want to risk the long term serious side effects like bone thinning, cognition and memory issues which can show up after 18 months to 2 years. I am going to discuss it with the oncologist in a few weeks during my next appointment.
I cannot common in DCIS invasive, so my comments are for IDC itself:
I don't personally know anyone who has cognition or memory issues on an AI, and I don't seem them listed as side effects.
I had severe osteoporosis, as I have written previously, and did 5 years on letrozole. Most people also take a biphosphonate during the AI treatment but I was unable to. I am now on Tymlos.
I would rather deal with some bone loss than cancer. The Breast Cancer Index, at the time I had that test, considered any risk over 4.7% as "high." It is up to your doc and you whether 3% versus 7% is significant.
Another factor might be your ER score. Since your Oncotype was low, I assume your ER% was high.
I would like to see study also